1 / 19

2 002 I NTERIM R ESULTS

2 002 I NTERIM R ESULTS. Highlights. HK$ YoY Growth (million) (%) Turnover 1,720 +6.4 Net Profit 485 -29.7 /-17.8 # Gross Profit 913 +10.3 EBITDA 720 -10.4 Interim dividend HK15 cents +7.1 # After discounting exceptional gain from Shanghai Jahwa spin-off listing in 2001.

vbarrett
Download Presentation

2 002 I NTERIM R ESULTS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 2002 INTERIM RESULTS

  2. Highlights HK$ YoY Growth (million)(%) • Turnover 1,720 +6.4 • Net Profit 485 -29.7 /-17.8 # • Gross Profit 913 +10.3 • EBITDA 720 -10.4 • Interim dividend HK15 cents +7.1 # After discounting exceptional gain from Shanghai Jahwa spin-off listing in 2001

  3. Reasons for profit decline • No exceptional gain in 1H2002 • Reduction of interest income • Slippage of Huizhong autoparts business • Share of attributable loss of SMIC due to depreciation and interest expenses

  4. Financial Position HK$ (billion) • Cash on hand 3.26 • Total borrowing 1.64 • Net cash 1.62 • Gearing ratio 10.9 % • Interest cover 17 times

  5. SECTOR REVIEW

  6. Infrastructure/Logistics Infrastructure facilities • Contributed HK$354M • Stable cash income from main arteries of Shanghai’s expressway network • Waigaoqiao Container Terminal Phase I received government approval; finalizing details regarding operation, capital contribution procedures and work schedules

  7. Infrastructure/Logistics Modern Logistics • Acquired control stakes in EAS international with 1100-city distributions network in China • Acquired controlling interests in CTII Worldwide Ltd.in Hong Kong (re-named EAS Worldwide Logistics) • Established management operation platform covering Beijing, Shanghai and Hong Kong

  8. Infrastructure/Logistics Modern Logistics • Shanghai Wai Lian Fa (at Waigaoqiao Free Trade Zone) • Actively expanding market share, secured a 80-company customer base, and 33,000-tonne warehouse delivery • Shanghai Sinotrans (at Chemical Industrial Zone) • Obtained business license and started operation in July 2002

  9. Infrastructure/Logistics Modern Logistics • Actively consolidate nationwide modern logistics business with newly acquired resources • Introduce international strategic partners to maximize exposure to fast-growing logistics demand in China

  10. Information Technology SMIC • Production capacity exceeded 10K wafers/m, to reach 30K wafers/m by year-end • Received 0.18-micron CMOS process certification; first foundry in China to produce 0.18-micron logic technology in volume • Secured technology partners including Toshiba, Fujitsu, Chartered • Formed partnership with IMEC in advanced semiconductor process technology • Expected to achieve break-even in Q4/2002

  11. Information Technology SII • Contributed RMB21.29M net profit, up 43% • Completed 40K cable TV subscribers upgrade, to reach 1.6M total by year-end • “Cableplus” broadband service secured 40K commercial subscribers • Shanghai Information Pipeline completed > 600 km of Shanghai government system service network; 1H2002 sales contract totalled RMB80M IT sector posted HK$28.5M loss due to attributable loss of SMIC

  12. Medicine and Bio-technology SIIC MedTech + Sunway Biotech, Mergen Ltd, Sunve Pharmaceutical SIIC MedTech • Contributed HK$29.3M net profit, up 5.3%* • Hangzhou Qingchunbao : • Qingchunbao Anti-aging Tablets sales up 70.4%, Shen Mai, Dan Shen, Huang Qi and Herba Houttuyniae injection medicines sales up 6.9%, 16.5%, 26.6%, 34.4% respectively * Ex-exceptional in 2001

  13. Medicine and Bio-technology SIIC MedTech • Shanghai Jahwa: • Liushen and Herborist products sales up 13% and 50% respectively; Herborist specialty stores expanding to Xian, Qingdao, Nanjing, Shenzhen, also entered Watson’s chain stores in Hong Kong

  14. Medicine and Bio-technology Sunway Biotech: • H101 anti-cancer medicine completed Phase 2 clinical trial, to commence Phase 3 in Sept; also launched H103 pre-clinical studies in U.S. and China simultaneously • Recorded net loss of RMB15.8M Sunve Pharmaceutical: • Self-developed new products received Shanghai Municipal New Product Award; Raw materials medicine passed FDA certification and entered U.S. Market • Recorded net profit of RMB4.75M Mergen: • Secured contract with CuraGen to provide microarrays supply, custom array design services; granted 2 patents for new DNA chips technology

  15. Consumer Products/Retailing Aggressive growth in 1H2002 Net Profit YoY Growth HK$M (%) • Nanyang Tobacco 46.78 +18.3 • Wing Fat Printing 43.00 +16.0 • Bright Dairy 89.25 +40.0 • Orient Shopping Centre 17.01 +23.0

  16. Consumer Products/Retailing Nanyang Tobacco • Maintained stable domestic sales in Hong Kong • Strengthened market share in Singapore • Entered Taiwan market • Sale of duty-free cigarettes up 103% Wing Fat Printing • Developed new tobacco packs for Nanyang • Increased tobacco packs production for European Tobacco Inc.

  17. Consumer Products/Retailing Bright Dairy • Bottled milk sales up 322% • New production facilities in Guangzhou and Beijing to start in 2H2002 • Listed at Shanghai Stock Exchange on August 28, over-subscribed by 584 times • To contribute HK$220M exceptional gain in 2H2002 Orient Shopping Centre • Organised mega sale events in store that helped boost sales

  18. Autoparts Shanghai Huizhong • Contributed RMB33.4M net profit, down 61% • Substantial price-cut of domestic-made sedans led to profit decline • Car sale expected to resume growth in 2H2002 Shanghai Wanzhong • Upgrading heavy truck production facilities to consolidate market share SIIC Transportation Electric • Contributed RMB11.38M net profit, up 56% • Focused on developing high value-added and high-tech auto parts • Enrolled 146 national dealers

  19. Outlook • Continue to focus on developing infrastructure, modern logistics, information technology and medicine and bio-technology businesses • Continue to leverage on sustained growth of Shanghai’s economy by investing in key development projects • Plan to divest non-core businesses by spin-off, internal re-organization or transfer • Poised to benefit from newly developed businesses such as semiconductor and modern logistics • Adopting stringent controls on operating costs and risks • Further improve corporate management to raise corporate governance standards

More Related